Amplia Therapeutics Limited Stock OTC Markets
Stocks
INNMF
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
03:24:21 2026-09-22 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.0917 USD | +9.90% |
|
+12.31% | +16.22% |
| Market Cap | 64.16M 45.6M 39.85M 37.46M 34.18M 64.15M 4.36B 450M 173M 2.23B 171M 168M 7.18B | P/E 2027 * |
-5.43x | P/E 2028 * | -17.9x |
|---|---|---|---|---|---|
| Enterprise Value | 46.26M 32.88M 28.73M 27.01M 24.65M 46.26M 3.14B 324M 125M 1.61B 123M 121M 5.17B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 4.29x |
| Free-Float |
90.48% | Yield 2027 * |
-
| Yield 2028 * | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ATX | Delayed | |
OTC Markets
| INNMF | Delayed |
| 1 day | +9.90% | ||
| 1 week | +12.31% | ||
| Current month | -8.30% | ||
| 1 month | -14.00% | ||
| 3 months | +14.62% | ||
| 6 months | +14.62% | ||
| Current year | +16.22% |
| 1 week | 0.08 |  | 0.1 |
| 1 month | 0.07 | | 0.1 |
| Current year | 0.06 | | 0.27 |
| 1 year | 0.05 | | 0.27 |
| 3 years | 0.02 | | 0.27 |
| 5 years | 0.02 | | 0.27 |
| 10 years | 0.01 | | 1.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2022-12-04 | |
Hamish George
DFI | Director of Finance/CFO | - | 2021-09-30 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 2015-09-01 |
Warwick Tong
CHM | Chairman | - | 2018-05-24 |
Jane Bell
CHM | Chairman | - | 2026-06-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.90% | +12.31% | - | - | 45.6M | |
| -0.07% | +7.14% | +53.95% | +111.00% | 74.27B | |
| -0.79% | -0.02% | +35.31% | +77.79% | 61.21B | |
| +0.28% | +5.73% | +33.67% | +20.82% | 27.55B | |
| -0.15% | +0.75% | -16.69% | +361.67% | 26.38B | |
| +2.93% | +4.32% | +2.18% | -3.60% | 25.34B | |
| +0.90% | +4.03% | +26.03% | -8.77% | 20.84B | |
| -1.47% | +4.86% | -5.94% | +519.63% | 14.94B | |
| +0.87% | -3.73% | +159.95% | +327.53% | 15.17B | |
| +1.63% | +2.20% | +46.92% | +170.72% | 14.41B | |
| Average | +1.39% | +3.17% | +37.26% | +175.20% | 31.12B | |
| Weighted average by Cap. | +0.20% | +3.44% | +36.65% | +135.80% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 9.5M 6.75M 5.9M 5.55M 5.06M 9.5M 645M 66.56M 25.68M 330M 25.36M 24.8M 1.06B |
| Net income | -11.6M -8.24M -7.2M -6.77M -6.18M -11.6M -788M -81.27M -31.36M -402M -30.96M -30.28M -1.3B | -4.1M -2.91M -2.55M -2.39M -2.18M -4.1M -279M -28.73M -11.08M -142M -10.94M -10.7M -459M |
| Net Debt | -17.9M -12.72M -11.12M -10.45M -9.54M -17.9M -1.22B -125M -48.39M -621M -47.78M -46.73M -2B | -23.4M -16.63M -14.53M -13.66M -12.47M -23.4M -1.59B -164M -63.26M -812M -62.46M -61.09M -2.62B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-22 | $0.0917 | +9.90% | 34,000 |
| 26-09-18 | $0.0835 | +6.31% | 5,000 |
| 26-09-17 | $0.0785 | +7.48% | 108,000 |
| 26-09-16 | $0.0730 | -10.55% | 32,811 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1250AUD
Average target price
0.4200AUD
Spread / Average Target
+236.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
- INNMF Stock
Select your edition
All financial news and data tailored to specific country editions
